Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dominion Resources

58.75
0.0000
Post-market: 58.750.00000.00%18:45 EDT
Volume:2.91M
Turnover:170.87M
Market Cap:50.10B
PE:21.91
High:58.98
Open:58.75
Low:58.45
Close:58.75
Loading ...

Dominion Energy Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Apr

Eversource Rides on Strategic Investments & Renewable Expansion

Zacks
·
31 Mar

Dominion Energy (NYSE:D) Faces Shareholder Proposal Over Executive Pay Tied To Non-Carbon Goals

Simply Wall St.
·
29 Mar

Directa SIM FY Net Profit EUR 11.3 Mln

T-Reuters
·
28 Mar

Dominion Energy Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 Mar

Economic Growth Now Depends on Electricity, Not Oil -- WSJ

Dow Jones
·
27 Mar

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

PR Newswire
·
26 Mar

Dominion Energy Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Mar

Is Dominion Energy (NYSE:D) Using Too Much Debt?

Simply Wall St.
·
25 Mar

Press Release: Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders

Dow Jones
·
24 Mar

Werner® Associate Recognized as a Supply & Demand Chain Executive 2025 Pros to Know Winner

Business Wire
·
21 Mar

Dominion Energy Is Maintained at Neutral by UBS

Dow Jones
·
21 Mar

UBS Adjusts Price Target on Dominion Energy to $60 From $58, Keeps Neutral Rating

MT Newswires Live
·
21 Mar

Is Dominion Energy, Inc. (D) the Best Nuclear Power Stock to Buy Now?

Insider Monkey
·
21 Mar

PPL Stock is Trading at a Premium: Should You Buy, Hold or Sell?

Zacks
·
20 Mar

Morgan Stanley Raises Dominion Energy Price Target to $63 From $60, Maintains Equal Weight Rating

MT Newswires Live
·
20 Mar

Dominion Energy (D) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
20 Mar

Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas

GlobeNewswire
·
19 Mar

Completed placing of shares in RaySearch Laboratories AB (publ)

PR Newswire
·
19 Mar

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation

PR Newswire
·
18 Mar